Stefan Michelfelder
0000-0001-8678-1546
Publication & Citation Trends
Publications
0 total
MSD-based assays facilitate a rapid and quantitative serostatus profiling for the presence of anti-AAV antibodies OA
Cited by 10
Semantic Scholar
Development of a Bispecific Antibody-Based Platform for Retargeting of Capsid Modified AAV Vectors OA
Cited by 14
Semantic Scholar
Human stem cell-based retina-on-chip as new translational model for validation of AAV retinal gene therapy vectors OA
Cited by 8
Semantic Scholar
Human stem cell-based retina on chip as new translational model for validation of AAV retinal gene therapy vectors OA
Cited by 40
Semantic Scholar
Recombinant Production of MFHR1, A Novel Synthetic Multitarget Complement Inhibitor, in Moss Bioreactors OA
Cited by 21
Semantic Scholar
The MFHR1 Fusion Protein Is a Novel Synthetic Multitarget Complement Inhibitor with Therapeutic Potential. OA
Cited by 33
Semantic Scholar
Moss-made complement therapeutics
Cited by 0
Semantic Scholar
Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders. OA
Cited by 46
Semantic Scholar
Research Topics
Virus-based gene therapy research
(17)
RNA Interference and Gene Delivery
(11)
Monoclonal and Polyclonal Antibodies Research
(7)
Immunotherapy and Immune Responses
(6)
CRISPR and Genetic Engineering
(6)
Affiliations
Boehringer Ingelheim (Germany)
Universität Hamburg
University of Freiburg
University Medical Center Freiburg
University Medical Center Hamburg-Eppendorf